Currently, out of the existing stock ratings of Biren Amin - 136 which are a Buy (83.95%), 25 which are a Hold (15.43%), 1 which are a Sell (0.62%)

Biren Amin

Work Performance Price Targets & Ratings Chart

Analyst Biren Amin works at JEFFERIES and is covering the Healthcare sector with 305 price targets and ratings displayed on 32 stocks.

Biren Amin's average stock forecast success ratio is 57.52% with an average time for price targets to be met of 205.79 days.

Most recent stock forecast was given on ALLO, Allogene Therapeutics at 01-Jul-2021.

Wall Street Analyst Biren Amin

Analyst best performing recommendations are on CCCC (C4 THERAPEUTICS).
The best stock recommendation documented was for ZYNE (ZYNERBA PHARMACEUTICALS) at 9/16/2019. The price target of $11 was fulfilled within 2 days with a profit of $0.51 (4.43%) receiving and performance score of 22.15.

Average potential price target upside

of $61.11 (12%) on REGN (REGENERON PHARMACEUTICALS).
of $30.81 (22.06%) on CLDX (CELLDEX THERAPEUTICS).
of $25.43 (35.35%) on ANAB (ANAPTYSBIO).

AGEN Agenus ALKS Alkermes plc ALLO Allogene Therapeutics BLCM Bellicum Pharmaceuticals BLUE bluebird bio CCCC C4 Therapeutics CRTX Cortexyme FATE Fate Therapeutics HRTX Heron Therapeutics IMGN ImmunoGen MDCO NBIX Neurocrine Biosciences NLNK REGN Regeneron Pharmaceuticals TRVN Trevena CLDX Celldex Therapeutics ACRX AcelRx Pharmaceuticals ANAB AnaptysBio CTMX CytomX Therapeutics IOVA Iovance Biotherapeutics LUMO Lumos Pharma KDMN ZYNE Zynerba Pharmaceuticals STML XENE Xenon Pharmaceuticals ARDX Ardelyx GLYC KALA Kala Pharmaceuticals NK OBSV ObsEva SA VSTM Verastem NERV Minerva Neurosciences

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Michael King (BENCHMARK)